| Gene Symbol | PLA2G2A |
| Entrez ID | 5320 |
| Uniprot ID | P14555 |
| Description | phospholipase A2 group IIA |
| Chromosomal Location | chr1: 19,975,431-19,980,416 |
| Ontology | GO ID | GO Term | Definition | Evidence |
|---|---|---|---|---|
|
BP |
GO:0006644 |
phospholipid metabolic process |
The chemical reactions and pathways involving phospholipids, any lipid containing phosphoric acid as a mono- or diester. |
IDA |
|
BP |
GO:0006654 |
phosphatidic acid biosynthetic process |
The chemical reactions and pathways resulting in the formation of phosphatidic acid, any derivative of glycerol phosphate in which both the remaining hydroxyl groups of the glycerol moiety are esterified with fatty acids. |
TAS |
|
BP |
GO:0010744 |
positive regulation of macrophage derived foam cell differentiation |
Any process that increases the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions. |
TAS |
|
BP |
GO:0016042 |
lipid catabolic process |
The chemical reactions and pathways resulting in the breakdown of lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. |
IEA |
|
BP |
GO:0034374 |
low-density lipoprotein particle remodeling |
The acquisition, loss or modification of a protein or lipid within a low-density lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase, with the subsequent loss of free fatty acid, and the transfer of cholesterol esters from LDL to a triglyceride-rich lipoprotein particle by cholesteryl ester transfer protein (CETP), with the simultaneous transfer of triglyceride to LDL. |
TAS |
|
BP |
GO:0036148 |
phosphatidylglycerol acyl-chain remodeling |
Remodeling the acyl chains of phosphatidylglycerol, through sequential deacylation and re-acylation reactions, to generate phosphatidylglycerol containing different types of fatty acid acyl chains. |
TAS |
|
BP |
GO:0036149 |
phosphatidylinositol acyl-chain remodeling |
Remodeling the acyl chains of phosphatidylinositol, through sequential deacylation and re-acylation reactions, to generate phosphatidylinositol containing different types of fatty acid acyl chains. |
TAS |
|
BP |
GO:0036150 |
phosphatidylserine acyl-chain remodeling |
Remodeling the acyl chains of phosphatidylserine, through sequential deacylation and re-acylation reactions, to generate phosphatidylserine containing different types of fatty acid acyl chains. |
TAS |
|
BP |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling |
Remodeling the acyl chains of phosphatidylcholine, through sequential deacylation and re-acylation reactions, to generate phosphatidylcholine containing different types of fatty acid acyl chains. |
TAS |
|
BP |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling |
Remodeling the acyl chains of phosphatidylethanolamine, through sequential deacylation and re-acylation reactions, to generate phosphatidylethanolamine containing different types of fatty acid acyl chains. |
TAS |
|
BP |
GO:0046473 |
phosphatidic acid metabolic process |
The chemical reactions and pathways involving phosphatidic acid, any derivative of glycerol phosphate in which both the remaining hydroxyl groups of the glycerol moiety are esterified with fatty acids. |
IDA |
|
BP |
GO:0050482 |
arachidonic acid secretion |
The controlled release of arachidonic acid from a cell or a tissue. |
IEA |
|
BP |
GO:0050729 |
positive regulation of inflammatory response |
Any process that activates or increases the frequency, rate or extent of the inflammatory response. |
TAS |
|
BP |
GO:0050830 |
defense response to Gram-positive bacterium |
Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism. |
TAS |
|
BP |
GO:0070374 |
positive regulation of ERK1 and ERK2 cascade |
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
IDA |
|
CC |
GO:0005576 |
extracellular region |
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
TAS |
|
CC |
GO:0005615 |
extracellular space |
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
IDA |
|
CC |
GO:0005783 |
endoplasmic reticulum |
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached). |
IDA |
|
CC |
GO:0005789 |
endoplasmic reticulum membrane |
The lipid bilayer surrounding the endoplasmic reticulum. |
TAS |
|
CC |
GO:0005886 |
plasma membrane |
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
IEA |
|
CC |
GO:0030141 |
secretory granule |
A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules. |
IEA |
|
CC |
GO:0048471 |
perinuclear region of cytoplasm |
Cytoplasm situated near, or occurring around, the nucleus. |
IEA |
|
CC |
GO:0070062 |
extracellular exosome |
A membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
IDA |
|
MF |
GO:0004623 |
phospholipase A2 activity |
Catalysis of the reaction: phosphatidylcholine + H2O = 1-acylglycerophosphocholine + a carboxylate. |
IDA|TAS |
|
MF |
GO:0005509 |
calcium ion binding |
Interacting selectively and non-covalently with calcium ions (Ca2+). |
IEA |
|
MF |
GO:0005543 |
phospholipid binding |
Interacting selectively and non-covalently with phospholipids, a class of lipids containing phosphoric acid as a mono- or diester. |
IDA |
|
MF |
GO:0047498 |
calcium-dependent phospholipase A2 activity |
Catalysis of the reaction: phosphatidylcholine + H2O = 1-acylglycerophosphocholine + a carboxylate. This reaction requires Ca2+. |
TAS |
| Domain ID | Description |
|---|---|
|
IPR001211 |
Phospholipase A2 |
|
IPR016090 |
Phospholipase A2 domain |
|
IPR033112 |
Phospholipase A2, aspartic acid active site |
|
IPR033113 |
Phospholipase A2, histidine active site |
| Pathway ID | Pathway Term | Pathway Source |
|---|---|---|
|
hsa00564 |
Glycerophospholipid metabolism |
KEGG |
|
hsa00565 |
Ether lipid metabolism |
KEGG |
|
hsa00590 |
Arachidonic acid metabolism |
KEGG |
|
hsa00591 |
Linoleic acid metabolism |
KEGG |
|
hsa00592 |
alpha-Linolenic acid metabolism |
KEGG |
|
hsa01100 |
Metabolic pathways |
KEGG |
|
hsa04014 |
Ras signaling pathway |
KEGG |
|
hsa04270 |
Vascular smooth muscle contraction |
KEGG |
|
hsa04972 |
Pancreatic secretion |
KEGG |
|
hsa04975 |
Fat digestion and absorption |
KEGG |
|
WP2431 |
Spinal Cord Injury |
WikiPathways |
|
WP167 |
Eicosanoid Synthesis |
WikiPathways |
|
WP2533 |
Glycerophospholipid Biosynthetic Pathway |
WikiPathways |
|
WP1544 |
MicroRNAs in cardiomyocyte hypertrophy |
WikiPathways |
|
WP2795 |
Cardiac Hypertrophic Response |
WikiPathways |
| UMLS CUI | UMLS Term |
|---|---|
|
C0004153 |
Atherosclerosis |
|
C0009404 |
Colorectal Neoplasms |
|
C0014175 |
Endometriosis |
|
C0035126 |
Reperfusion Injury |
|
C0151744 |
Myocardial Ischemia |
| Pubmed ID | Author | Year | Title |
|---|---|---|---|
|
15308691 |
Jansen et al. |
2004 |
Abnormal Gene Expression Profiles in Human Ovaries from Polycystic Ovary Syndrome Patients |
| Gene Symbol | Entrez ID | Uniprot ID | Score |
|---|---|---|---|
|
PLCG2 |
5336 |
P16885 |
0.00 |
|
PRKCD |
5580 |
Q05655 |
0.00 |
|
VCAN |
1462 |
P13611 |
0.62 |
|
BAG6 |
7917 |
P46379 |
0.63 |
|
CRELD2 |
79174 |
Q6UXH1 |
0.63 |
|
CEP70 |
80321 |
Q8NHQ1 |
0.63 |
|
ALOX12 |
239 |
P18054 |
0.65 |
|
VIM |
7431 |
P08670 |
0.68 |
|
PLA2G1B |
5319 |
P04054 |
0.75 |
|
PLA2G2A |
5320 |
P14555 |
0.84 |
|
DCN |
1634 |
P07585 |
0.86 |
|
GNA11 |
2767 |
P29992 |
0.00 |
|
GNAO1 |
2775 |
P09471 |
0.00 |
|
GNAQ |
2776 |
P50148 |
0.00 |
|
GNAZ |
2781 |
P19086 |
0.00 |
|
MAPK3 |
5595 |
P27361 |
0.00 |
|
GNA13 |
10672 |
Q14344 |
0.00 |
|
UCHL1 |
7345 |
P09936 |
0.52 |
|
UCHL3 |
7347 |
P15374 |
0.52 |
|
USP4 |
7375 |
Q13107 |
0.52 |
|
USP7 |
7874 |
Q93009 |
0.52 |
|
USP5 |
8078 |
P45974 |
0.52 |
|
USP2 |
9099 |
O75604 |
0.52 |
|
USP8 |
9101 |
P40818 |
0.52 |
|
USP15 |
9958 |
Q9Y4E8 |
0.52 |
|
USP20 |
10868 |
Q9Y2K6 |
0.52 |
|
PLA2R1 |
22925 |
Q13018 |
0.52 |
|
SENP6 |
26054 |
Q9GZR1 |
0.52 |
|
UCHL5 |
51377 |
Q9Y5K5 |
0.52 |
|
USP47 |
55031 |
Q96K76 |
0.52 |
|
USP28 |
57646 |
Q96RU2 |
0.52 |
|
SENP8 |
123228 |
Q96LD8 |
0.52 |
|
JOSD2 |
126119 |
Q8TAC2 |
0.52 |
|
CRMP1 |
1400 |
Q14194 |
0.63 |